| 1.
|
Describe the general anatomy and physiology of the endocrine system to
include the adrenal, pituitary, and parathyroid glands. (I)
|
| 2.
|
Describe pathological conditions of the endocrine system to include
hypoadrenalism, hyperadrenalism hyperfunctioning, hypofunctioning
pituitary gland, and other specific forms of pathology. (II)
|
| 3.
|
Explain imaging of the adrenal gland to include rationale,
indications, patient preparation, radiopharmaceutical, equipment,
technique, image interpretation, and other specific imaging
techniques. (III)
|
| 4.
|
Explain imaging of the parathyroid and pituitary glands to include
rationale, indications, patient preparation, radiopharmaceutical,
equipment, technique, and image interpretation. (IV)
|
| 5.
|
Describe the anatomy and physiology of specific soft-tissue structures
including, but not limited to, connective and nerve tissues. (V)
|
| 6.
|
Describe pathological conditions of soft-tissue structures to include
cellular inflammatory, neoplastic, chemical, allergic, congenital,
idiopathic conditions and other specific forms of pathology. (VI)
|
| 7.
|
Describe imaging procedures of the soft-tissues to include rationale,
indications, patient preparation, radiopharmaceutical, equipment,
technique, special considerations, image interpretation and other
specific imaging techniques. (VII)
|
| 8.
|
Describe the following nonorgan imaging studies to include combined
liver/lung, breast, dacroscintigraphy, radionuclide venography,
antibody imaging, in-vitro, LeVeen shunt procedures, and other special
organ systems. (VIII)
|
| 9.
|
Describe the specific pathology treated through therapeutic nuclear
medicine techniques to include hyperthyroidism, thyroid carcinoma,
euthyroid heart disease, polycythemia vera, chronic leukemia,
malignant lymphoma, metastatic bone disease, malignant pericardial
effusion, malignant peritoneal effusion, malignant pleural effusion,
ovarian carcinoma, and other forms of pathology. (IX)
|
| 10.
|
Describe the indications, preparation, quality control, and biological
behavior of the radiopharmaceuticals used in nuclear medicine
therapeutic procedures. (X)
|
| 11.
|
Explain nuclear medicine therapeutic procedures to include patient
preparation, personnel and laboratory preparation, administration of
the radiopharmaceutical, post-therapeutic procedures, special
considerations, and radiation safety. (XI)
|
| 12.
|
Describe the principles of radioassay to include terminology, test
substances, review of solution chemistry, competitive radioassay,
sequential saturation analysis, sandwich assay, immunoradiometric
assay, radioenzymatic assay, radioreceptor assay, and
radioallergosorbent test. (XII)
|
| 13.
|
Explain specific principles related to immunology to include
terminology, nonspecific immunity, and specific immunity. (XIII)
|
| 14.
|
Describe specific clinical techniques involved with radioassay to
include equipment, data reduction, record keeping, quality assurance,
troubleshooting, proficiency testing, radiation safety, specimen
storage, infection control, and instrumentation quality control. (XIV)
|
| 15.
|
Explain specific assay procedures to include pituitary and
hypothalamic hormones, thyroid, parathyroids, adrenal glands, kidney,
pancreas, digestive, ovaries and testes, hepatitis, and
tumor-associated testing. (XV)
|
| 16.
|
Explain nonradioactive assays to include enzyme-linked immunosorbent
assay, enzyme multiplied immunoassay technique, and fluorometric
studies. (XVI)
|
| 17.
|
Describe fundamental principles of Positron Emission Tomography
(P.E.T.) and Single-Photon Emission Computerized Tomography
(S.P.E.C.T.) imaging to include theory, equipment,
radiopharmaceuticals, indications, and applications. (XVII)
|
| 18.
|
Describe other imaging modalities to include radiography, ultrasound,
computerized tomography, and magnetic resonance. (XVIII)
|
|